Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration

PURPOSE: Neovascular age-related macular degeneration (nv-AMD) is the leading cause of blindness in individuals 55 years and older. The advent of anti-vascular endothelial growth factor (anti-VEGF) therapy has greatly altered the visual acuity (VA) prognosis in these patients. While many studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Veluswamy, Balaji, Lee, Andy, Mirza, Rukhsana G, Gill, Manjot K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293965/
https://www.ncbi.nlm.nih.gov/pubmed/32606571
http://dx.doi.org/10.2147/OPTH.S256009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293965/
https://www.ncbi.nlm.nih.gov/pubmed/32606571
http://dx.doi.org/10.2147/OPTH.S256009

Ejemplares similares